FALCO HOLDINGS Past Earnings Performance
Past criteria checks 1/6
FALCO HOLDINGS has been growing earnings at an average annual rate of 21.2%, while the Healthcare industry saw earnings growing at 6% annually. Revenues have been growing at an average rate of 1.8% per year. FALCO HOLDINGS's return on equity is 7.7%, and it has net margins of 4.6%.
Key information
21.2%
Earnings growth rate
21.3%
EPS growth rate
| Healthcare Industry Growth | 7.9% |
| Revenue growth rate | 1.8% |
| Return on equity | 7.7% |
| Net Margin | 4.6% |
| Next Earnings Update | 10 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How FALCO HOLDINGS makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 43,349 | 1,996 | 9,601 | 0 |
| 30 Sep 23 | 44,087 | 1,765 | 9,797 | 0 |
| 30 Jun 23 | 45,985 | 1,943 | 10,056 | 0 |
| 31 Mar 23 | 46,913 | 2,261 | 10,129 | 0 |
| 31 Dec 22 | 49,444 | 2,550 | 10,466 | 0 |
| 30 Sep 22 | 49,465 | 2,533 | 10,546 | 0 |
| 30 Jun 22 | 49,552 | 3,130 | 10,345 | 0 |
| 31 Mar 22 | 50,007 | 3,533 | 10,309 | 0 |
| 31 Dec 21 | 48,100 | 3,451 | 9,906 | 0 |
| 30 Sep 21 | 47,910 | 3,641 | 9,776 | 0 |
| 30 Jun 21 | 45,878 | 2,948 | 9,616 | 0 |
| 31 Mar 21 | 43,608 | 1,853 | 9,516 | 0 |
| 31 Dec 20 | 42,347 | 776 | 10,846 | 0 |
| 30 Sep 20 | 41,643 | 1,305 | 11,003 | 0 |
| 30 Jun 20 | 42,025 | 789 | 11,167 | 0 |
| 31 Mar 20 | 43,185 | 1,243 | 11,261 | 0 |
| 31 Dec 19 | 43,406 | 1,184 | 11,224 | 0 |
| 30 Sep 19 | 44,007 | 402 | 11,114 | 0 |
| 30 Jun 19 | 43,751 | 649 | 11,142 | 0 |
| 31 Mar 19 | 44,156 | 653 | 11,228 | 0 |
| 31 Dec 18 | 44,915 | 1,347 | 11,132 | 0 |
| 30 Sep 18 | 45,110 | 1,434 | 11,227 | 0 |
| 30 Jun 18 | 45,673 | 1,551 | 11,193 | 0 |
| 31 Mar 18 | 45,962 | 1,697 | 11,217 | 0 |
| 31 Dec 17 | 45,811 | 1,676 | 11,189 | 0 |
| 30 Sep 17 | 45,665 | 1,593 | 11,134 | 0 |
| 30 Jun 17 | 45,806 | 1,630 | 11,232 | 0 |
| 31 Mar 17 | 45,971 | 1,478 | 11,321 | 0 |
| 31 Dec 16 | 47,025 | 1,428 | 11,559 | 0 |
| 30 Sep 16 | 47,960 | 1,487 | 11,811 | 0 |
| 30 Jun 16 | 48,323 | 1,233 | 11,964 | 0 |
| 31 Mar 16 | 48,727 | 1,347 | 11,959 | 0 |
| 31 Dec 15 | 48,132 | 1,220 | 11,855 | 0 |
| 30 Sep 15 | 47,411 | 1,210 | 11,666 | 0 |
| 30 Jun 15 | 47,065 | 1,179 | 11,564 | 0 |
| 31 Mar 15 | 46,593 | 1,117 | 11,530 | 0 |
| 31 Dec 14 | 46,262 | 519 | 11,397 | 0 |
| 30 Sep 14 | 50,250 | 2,068 | 12,255 | 0 |
| 30 Jun 14 | 54,262 | 2,095 | 13,034 | 0 |
| 31 Mar 14 | 58,401 | 2,278 | 13,713 | 0 |
| 31 Dec 13 | 63,497 | 3,040 | 14,524 | 0 |
| 30 Sep 13 | 63,174 | 1,492 | 14,344 | 0 |
| 30 Jun 13 | 63,053 | 1,465 | 14,236 | 0 |
Quality Earnings: 4671 has a large one-off gain of ¥768.0M impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: 4671's current net profit margins (4.6%) are lower than last year (5.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4671's earnings have grown significantly by 21.2% per year over the past 5 years.
Accelerating Growth: 4671's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 4671 had negative earnings growth (-21.7%) over the past year, making it difficult to compare to the Healthcare industry average (8.4%).
Return on Equity
High ROE: 4671's Return on Equity (7.7%) is considered low.